Company Profile

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Applying our Manoceptâ„¢ technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. The company, founded in 1983, maintains headquarters in Dublin, Ohio.

Contact Information

Investor Relations
Joel H. Kaufman
Chief Business Officer
T: 614-822-2372
jkaufman@navidea.com

Company Contact
Navidea Biopharmaceuticals, Inc.
4995 Bradenton Avenue
Dublin, OH 43017